Continuous infusion of GIP for 6 days nonetheless increases hepatic fat content in people living with T1D [809], and fat-specific overexpression of GIPR leads to protection from diet-induced obesity [799], overall supporting that GIP increases adipose tissue lipid utilization under conditions of insulin resistance. The gene discussed is GIP; the disease is Obesity.